Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
Ebiomedicine|September 27, 2023
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malariaMavuto Mukaka, Marie A Onyamboko, Peter Olupot-Olupot, et al.
Elife|February 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The New England Journal of Medicine|March 1, 2023
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub TyphusGeorge M Varghese, Divya Dayanand, Karthik Gunasekaran, et al.
The Lancet. Infectious Diseases|March 11, 2022
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trialThomas J Peto, Rupam Tripura, James J Callery, et al.
Plos Medicine|June 13, 2018
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge, Lesley Workman, Steffen Borrmann, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
BMC Medicine|June 3, 2020
Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisMakoto Saito, Rashid Mansoor, Kalynn Kennon, et al.
The Lancet. Infectious Diseases|June 13, 2020
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysisMakoto Saito, Rashid Mansoor, Kalynn Kennon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label TrialKatherine Plewes, Hugh W F Kingston, Aniruddha Ghose, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Elife|January 9, 2023
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot studyBarnaby Flower, Le Manh Hung, Leanne Mccabe, et al.
Ebiomedicine|September 27, 2023
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malariaMavuto Mukaka, Marie A Onyamboko, Peter Olupot-Olupot, et al.
Elife|February 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The New England Journal of Medicine|March 1, 2023
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub TyphusGeorge M Varghese, Divya Dayanand, Karthik Gunasekaran, et al.
The Lancet. Infectious Diseases|March 11, 2022
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trialThomas J Peto, Rupam Tripura, James J Callery, et al.
Plos Medicine|June 13, 2018
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysisFrank Kloprogge, Lesley Workman, Steffen Borrmann, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
BMC Medicine|June 3, 2020
Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisMakoto Saito, Rashid Mansoor, Kalynn Kennon, et al.
The Lancet. Infectious Diseases|June 13, 2020
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysisMakoto Saito, Rashid Mansoor, Kalynn Kennon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label TrialKatherine Plewes, Hugh W F Kingston, Aniruddha Ghose, et al.
Pageof 25